A in Vivo Assay for Standardizing Heparin Preparations

Summary

The limitations of currently used in vitro assays of heparin have demonstrated the need for an in vivo method suitable for routine use.

The in vivo method which is described in this paper uses, for each heparin preparation, four groups of five mice which are injected intravenously with heparin according to a “2 and 2 dose assay” procedure. The method is relatively rapid, requiring 3 to 4 hours to test five heparin preparations against a standard preparation of heparin. Levels of accuracy and precision acceptable for the requirements of the British Pharmacopoeia are obtained by combining the results of 3 to 4 assays of a heparin preparation.

The similarity of results obtained the in vivo method and the in vitro method of the British Pharmacopoeia for heparin preparations of lung and mucosal origin validates this in vivo method and, conversely, demonstrates that the in vitro method of the British Pharmacopoeia gives a reliable estimation of the in vivo activity of heparin.

• References

• 1 Bangham DR, Woodward PM. 1970; A collaborative study of heparins from different sources. Bulletin of the World Health Organization 42: 129
• 2 Blomback B, Blomback M, Corneliusson EV, Jorpes JE. 1953; On the reliability of the methods used in the assay of heparin. Journal of Pharmacy and Pharmacology 5: 1031
• 3 British Pharmacopoeia. 1968. Her Majesty’s Stationery Office; London: P 1296
• 4 British Pharmacopoeia. 1973. Her Majesty’s Stationery Office; London: P A 112
• 5 Jorpes EJ, Blomback M, Blomback B. 1954; An in vivo method for the assay of heparin. Journal of Pharmacy and Pharmacology 6: 694
• 6 Kuo SH, Jaques LB, Millar GJ. 1972; An improved in vivo procedure for standardization of heparin preparations. Journal of Pharmacy and Pharmacology 24: 858
• 7 Rezansoff WE, Jaques LB. 1967; An investigation of the assay of heparin based on its activity in vivo. Thrombosis et Diathesis Haemorrhagica 18: 150
• 8 Walton PL, Ricketts CR, Bangham DR. 1966; Heterogeneity of heparin. British Journal of Haematology 12: 310
• 9 W.H.O. Expert Committee On Biological Standardization. 1969; Heparins. World Health Organization Technical Report Series 413: 17